Which of the following drug has a favourable effect on lipid metabolism ?
First, the core concept here is lipid-lowering drugs. Common ones include statins, fibrates, niacin, and others. The question is testing knowledge of drug mechanisms affecting lipids.
Assuming the options include drugs like Atorvastatin (a statin), Fenofibrate (a fibrate), Ezetimibe, and maybe something like Niacin. The correct answer would be a statin, as they are first-line for LDL reduction.
Why the correct answer is right: Statins inhibit HMG-CoA reductase, reducing cholesterol synthesis, increasing LDL receptors, which lowers LDL-C. They also have modest effects on triglycerides and HDL.
For the wrong options: If one option is a beta-blocker like Propranolol, that's incorrect because beta-blockers can increase triglycerides and lower HDL. Another wrong option could be a thiazide diuretic, which might worsen lipid profiles. If another drug is a fibrate, that's actually correct for certain lipid issues but maybe not the best answer if the question is about overall favorable effects. Wait, the question says "favorable effect on lipid metabolism" in general. So statins are the best answer.
Clinical pearl: Remember statins as first-line for dyslipidemia. They lower LDL, increase HDL slightly, and are associated with cardiovascular risk reduction.
Now, structuring the explanation. Need to make sure each section is covered concisely. Check for medical accuracy, use correct terminology. Ensure the wrong options are explained with why they're incorrect. Keep within the character limit. Avoid markdown in the thinking, but the final answer must have the sections as specified.
**Core Concept**
This question assesses understanding of lipid-lowering drugs and their mechanisms. Statins, fibrates, and niacin are primary agents that modulate lipid metabolism by targeting cholesterol synthesis, absorption, or triglyceride metabolism.
**Why the Correct Answer is Right**
**Option C: Atorvastatin** is a statin that inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. This reduces hepatic VLDL production, increases LDL receptor expression (lowering LDL-C), and modestly raises HDL-C. It is first-line for hyperlipidemia and cardiovascular risk reduction.
**Why Each Wrong Option is Incorrect**
**Option A: Propranolol** is a beta-blocker. Beta-blockers may worsen lipid profiles by increasing triglycerides and decreasing HDL-C.
**Option B: Hydrochlorothiazide** is a diuretic. Thiazides can elevate LDL-C and triglycerides, particularly in patients with metabolic syndrome.
**Option D: Prednisolone** is a corticosteroid. Glucocorticoids increase hepatic lipogenesis, raising triglycerides and LDL-C while decreasing HDL-C.
**Clinical Pearl / High-Yield Fact**
Statins (e.g., atorvastatin) are the gold standard for lipid management due to their LDL-lowering efficacy and cardiovascular benefits. Avoid beta-blockers and corticosteroids in patients with